Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is not known to damage teeth directly. No mechanism in the medicine itself targets dental tissue, and tooth changes are not listed as a recognised side effect in the UK Mounjaro licence. That said, several effects of treatment — particularly on saliva, diet and acid exposure — can affect oral health indirectly, and understanding the connection is genuinely useful. These are prescription-only medicines; a clinical assessment by a qualified prescriber is required before anyone can start treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is no, not in any way the evidence currently supports. Tirzepatide works as a dual GIP and GLP-1 receptor agonist, slowing gastric emptying and reducing appetite; neither pathway has a known direct action on enamel, dentine or gum tissue. The UK patient information for Mounjaro, which you can read in full on the NHS tirzepatide medicines page, does not list tooth decay, gum disease or enamel erosion among the side effects recorded in clinical trials.
That is genuinely reassuring. However, it is worth separating what the medicine does from what happens to your body while taking it, because some of those secondary changes do reach the mouth. You will find a fuller treatment overview on the Mounjaro pillar page if you want the wider clinical picture.
One thing our prescribers are asked about most weeks: people searching online for "Mounjaro and teeth" or "tirzepatide teeth" have often come across social media posts describing dental problems. In the majority of cases those posts describe experiences shared across several GLP-1 medicines, and if you are wondering whether Trulicity is the same as Mounjaro, that page explains how these medicines relate to one another and why reported side effect patterns can overlap. The mechanism (where one exists) is almost always indirect.
Quite possibly, yes. Mounjaro significantly reduces appetite; many people eat far less, snack rarely and drink fewer sugary drinks. On the surface that sounds good for teeth. The complication is saliva. Saliva is your mouth's natural defence, it buffers acid, remineralises enamel and washes away bacteria. When you eat less frequently, saliva flow can drop between meals, leaving teeth slightly more exposed for longer.
Separately, a dry mouth is listed as an occasional side effect of tirzepatide treatment. Dehydration (which can occur if nausea leads to reduced fluid intake) compounds this further. Lower saliva production is associated with a modest increase in cavity risk over time, independent of the medicine causing it.
There is also the question of what people do eat on treatment. Appetite changes often steer people towards softer, sometimes more acidic foods. Some people sip sparkling water more than before. None of these habits are harmful on their own, but layered together they are worth being aware of. If you are curious about the cost side of treatment, the Mounjaro cost guide covers what a private prescription typically includes.
Drinking plenty of plain water, spacing meals and maintaining a regular dental routine are practical, low-effort ways to keep these risks in check. Your dentist does not need to know your full medical history to advise you, but telling them you are on a treatment that can reduce appetite and saliva flow gives them useful context.
Gastric reflux is listed among the gastrointestinal side effects of tirzepatide, and the MHRA Yellow Card scheme continues to monitor reports across GLP-1 medicines. Acid reflux matters for teeth because repeated exposure of enamel to stomach acid causes erosion over time, a process entirely separate from bacterial decay but equally real in its effect on tooth structure.
Mounjaro slows the rate at which the stomach empties. For most people this is the mechanism behind feeling full for longer, which is central to how it supports weight loss. For some, it can also mean stomach contents, including acid, are more likely to reflux upwards, particularly when lying down or after eating too quickly. The overview of Mounjaro's physical effects touches on how the medicine's impact varies across different parts of the body.
If reflux is something you experience on treatment, it is worth raising with your prescriber rather than managing silently. Practical measures (not eating close to bedtime, sleeping with the head slightly elevated, avoiding very large meals) are often enough. Your dentist can also apply protective treatments if erosion is detected early. The detail on how dental symptoms connect to wider reported experiences is covered on the dedicated page on Mounjaro and tooth health.
Nothing extraordinary, but a few habits make a meaningful difference. Brush twice daily with a fluoride toothpaste; do not brush immediately after a reflux episode or an acidic drink, as enamel is temporarily softened and brushing can accelerate erosion. Wait around 30 minutes. Use a straw for acidic drinks. Keep your mouth hydrated, especially if you are eating less than usual and notice your mouth feeling drier.
Tell your dentist you are on a medicine that slows gastric emptying and can cause occasional dry mouth or reflux. You do not need to go into further detail unless you want to. A check-up every six months remains the right interval for most adults, and your dentist can monitor for early signs of erosion or increased cavitation before they become significant.
There is a broader discussion of reported experiences and what the current evidence does and does not show on the Mounjaro teeth issues page. For anyone weighing up whether this treatment is right for them, the weight-loss treatment overview explains the full landscape of licensed options in the UK.
Mounjaro is a prescription-only medicine; a prescriber reviews every application on its own clinical merits. If you have questions about whether treatment is appropriate for you, speaking to our prescribers via a free consultation is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.